Skip to main content
Clinical Trials/NCT03357718
NCT03357718
Completed
Phase 4

Oral Dexmedetomidine vs Midazoam For Premedication And Emergence Delirium in Children Undergoing Dental Treatment

Aydin Adnan Menderes University0 sites52 target enrollmentNovember 1, 2016

Overview

Phase
Phase 4
Intervention
Precedex
Conditions
Premedication
Sponsor
Aydin Adnan Menderes University
Enrollment
52
Primary Endpoint
Ramsey Sedation Scale
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study was to compare the effect of 2 µg/kg of oral dexmedetomidine (DEX) and 0.5 mg/kg dormicum as premedication among children undergoing dental procedures.

Detailed Description

The study involved 52 children between 3-7 years of age, ASA I , who underwent full-mouth dental rehabilitation. The DEX group (n=26) received 2 µg/kg DEX in apple juice, and the control group (n=26) received 0.5 mg/kg midazolam in apple juice. The patients' scores on the Ramsey sedation scale (RSS), parental separation anxiety scale, mask acceptance scale, post-anesthesia emergence delirium scale (PAEDS), and hemodynamic parameters were recorded. The data were analyzed using chi-square test, Fisher's exact test, student t test, and analysis of variance in SPSS.

Registry
clinicaltrials.gov
Start Date
November 1, 2016
End Date
June 1, 2017
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Aydin Adnan Menderes University
Responsible Party
Principal Investigator
Principal Investigator

Sultan KELES

Assist. Prof.Dr.

Aydin Adnan Menderes University

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria is age between 3 to 7 years and American Society og Anesthesiology (ASA) grade 1.

Exclusion Criteria

  • The exclusion criteria included congenital disease, DEX, propofol allergy, asthma, mental retardation and those children parents refuse to participate study.

Arms & Interventions

Dexmedetomidine

2 µg/kg Precedex

Intervention: Precedex

Midazolam

0.5 mg/kg dormicum

Intervention: Midazolam

Outcomes

Primary Outcomes

Ramsey Sedation Scale

Time Frame: 45 minutes after premedication

Sedation level is evaluated due to patient behavior. 1= Patient is anxious and agitated or restless or both, 2=Patient is cooperative, oriented, and tranquil, 3=Patient responds to command only, 4=Patient exhibits brisk response to light glabellar tap, 5=Patient exhibits sluggish response to light glabellar tap, 6=Patient exhibits no response.A Ramsay sedation score '1' was considered as unsatisfactory and "≥ 2" was considered as satisfactory sedation.

Secondary Outcomes

  • Parental Separation Anxiety Scale(Preoperative)
  • Mask Acceptance Score(Before induction)

Similar Trials